Invention Grant
- Patent Title: 1,8-naphthyridine compounds for the treatment of cancer
- Patent Title (中): 用于治疗癌症的1,8-萘啶化合物
-
Application No.: US13360558Application Date: 2012-01-27
-
Publication No.: US08765954B2Publication Date: 2014-07-01
- Inventor: Daniel C. Adelman , Marc J. Evanchik , Anantha Sudhakar , Jeffrey William Jacobs , Jeffrey A. Silverman
- Applicant: Daniel C. Adelman , Marc J. Evanchik , Anantha Sudhakar , Jeffrey William Jacobs , Jeffrey A. Silverman
- Applicant Address: US CA South San Francisco
- Assignee: Sunesis Pharmaceuticals, Inc.
- Current Assignee: Sunesis Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Jones Day
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/4375
Abstract:
Compounds and compositions for treating, preventing or managing cancer are disclosed. The compositions provided herein comprise SNS-595 and N-desmethyl-SNS-595. Also provided are pharmaceutical compositions comprising the compounds and methods of treatment using the compounds and compositions.
Public/Granted literature
- US20120245198A1 COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF CANCER Public/Granted day:2012-09-27
Information query
